W. J. D. Laird

The metabolism of cypermethrin in man: differences in urinary metabolite profiles following oral and dermal administration

B.H. Woollen, J. R. Marsh, W. J. D. Laird et al. · Xenobiotica · 1992 · 207 citations

Pharmaceutical Science, Pesticide-residue Analysis, Metabolomic Profiling +19

Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects [see comments]

J W Mier, Gloria Vachino, MS Klempner et al. · Blood · 1990 · 110 citations · Full text

Metabolism and pharmacokinetics of deuterium-labelled di-2-(ethylhexyl) adipate (DEHA) in humans

Neil Loftus, W. J. D. Laird, G. T. Steel et al. · Food and Chemical Toxicology · 1993 · 27 citations

Metabolic Syndrome, Energy Metabolism, Aldehyde Dehydrogenase +11

Oral Pharmacokinetics of Fluazifop-Butyl in Human Volunteers

B.H. Woollen, Taylor Hart, Peter L. Batten et al. · Human & Experimental Toxicology · 1991 · 14 citations

Metabolism of 2-(4-methylsulphonyl-2-nitrobenzoyl)-1,3-cyclohexanedione (mesotrione) in rat and mouse

A. J. Gledhill, Brian K. Jones, W. J. D. Laird · Xenobiotica · 2001 · 12 citations

Gastrointestinal Pharmacology, Species Differences, Digestive Tract +16